A potential, although modest, increase in the risk of a rare eye condition that is sometimes called “eye stroke” was found in patients with Type 2 diabetes who use semaglutide, also used for weight loss, new research finds.
The study authors also stated, “In the absence of a known mechanism for this association, we urge clinicians to weigh the concern for an increased risk of a rare but potentially blinding eye condition with the many therapeutic benefits of semaglutide.”
Sudden Vision Loss
The condition, called non-arteritic anterior ischemic optic neuropathy (NAION), occurs when blood flow to the optic nerve is blocked, potentially causing sudden vision loss, hence the term “eye stroke.”…